Millions of Americans with chronic conditions could save money on the drugs and medical services they need the most, if their health insurance plans decide to take advantage of a new federal rule issued July 17. And the idea behind that rule was born at the University of Michigan.
The U.S. Department of the Treasury gave health insurers more flexibility to cover the cost of certain medications and tests for people with common chronic conditions who are enrolled in many high-deductible health plans.
The rule change came about in part because of research and over a decade of policy engagement by University of Michigan professor Dr. A. Mark Fendrick and colleagues at the University of Michigan Center for Value-Based Insurance Design.
“As more and more Americans are facing high deductibles, they are struggling to pay for their essential medical care,” said Dr. Fendrick, a professor at the University of Michigan School of Public Health and U-M Medical School. “Our research has shown that this policy has the potential to lower out-of-pocket costs, reduce federal health care spending, and ultimately improve the health of millions diagnosed with chronic medical conditions. We have actively advocated for this policy change for over a decade.”
Dr. Fendrick is an internal medicine physician at Michigan Medicine and a member of the University of Michigan Institute for Healthcare Policy and Innovation.Friday Letter Submission, Publish on August 09